Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · IEX Real-Time Price · USD
4.520
+0.020 (0.44%)
Apr 23, 2024, 4:00 PM EDT - Market closed
Orchestra BioMed Holdings Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for OBIO stock have an average target of 17, with a low estimate of 14 and a high estimate of 20. The average target predicts an increase of 276.11% from the current stock price of 4.52.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OBIO stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +342.48% | Mar 28, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +209.73% | Jan 19, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +342.48% | Aug 11, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +342.48% | Aug 9, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +342.48% | May 15, 2023 |
Financial Forecast
Revenue This Year
3.95M
from 2.76M
Increased by 43.15%
Revenue Next Year
3.97M
from 3.95M
Increased by 0.56%
EPS This Year
-1.63
from -1.48
EPS Next Year
-1.82
from -1.63
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.3M | 5.3M | 5.3M |
| Avg | 4.0M | 4.0M | 3.0M |
| Low | 3.0M | 2.7M | 852,600 |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 90.2% | 32.9% | 32.1% |
| Avg | 43.2% | 0.6% | -24.6% |
| Low | 10.1% | -30.8% | -78.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.55 | -1.64 | -1.46 |
| Avg | -1.63 | -1.82 | -1.42 |
| Low | -1.64 | -1.96 | -1.36 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.